Holding(s) in Company
Updated : 15:59
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i | |||
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: | ENERGEAN OIL & GAS PLC | ||
2. Reason for the notification (please mark the appropriate box or boxes with an "X") | |||
An acquisition or disposal of voting rights | X | ||
An acquisition or disposal of financial instruments | |||
An event changing the breakdown of voting rights | |||
Other (please specify)iii: | |||
3. Details of person subject to the notification obligationiv | |||
Name |
| ||
4. Full name of shareholder(s) (if different from 3.)v | |||
Name | N/A | ||
City and country of registered office (if applicable) | |||
5. Date of the transaction and date on which the threshold is crossed or reached: | 28 September 2018 | ||
6. Date on which issuer notified (DD/MM/YYYY): | 10 October 2018 | ||
7. Threshold(s) that is/are crossed or reached: vi, vii | Below 11% | ||
8. Notified details | ||||||||||||
A: Voting rights attached to shares | ||||||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||
Number of shares | Number of voting rights | Number of shares | Number of Voting Rights | % of voting rights | ||||||||
Direct
| Direct
| Indirect
| Direct
| Indirect
| ||||||||
Ordinary shares | 17,622,268 | 11.53% | 855,044 | 855,044 | 15,608,034 | 0.56% | 10.21% | |||||
| ||||||||||||
B: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | ||||||||||||
Type of financial instrument | Expiration | Exercise/ | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights | ||||||||
N/A | ||||||||||||
| ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||
Type of financial instrument | Exercise Price | Expiration | Exercise/ | Number of voting rights instrument refers to | % of voting rights | |||||||
N/A | Nominal | Data | ||||||||||
| ||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | |
Clal Insurance Company Ltd. ("Clal") controls directly or indirectly the voting rights attached to a total of 16,463,078 ordinary shares in Energean Oil & Gas Plc ("Energean") through several of its controlled undertakings, as stated below: Of total of 16,463,078 ordinary shares (a) 855,044 Ordinary Shares are beneficially held for its own account; and (b) 15,608,034 Ordinary Shares are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by Clal and subsidiaries of Clal (Clal Pension and Provident funds Ltd. and Atudot Pension Fund for Workers & Independent Workers Ltd.) which operates under independent management and make independent voting and investment decisions. The 16,463,078 ordinary shares represent 10.77% of the voting rights attached to Energean's shares (based on the total number of issued shares in Energean being 152,823,238 ordinary shares). | |
10. In case of proxy voting, please identify: | |
Name of the proxy holder | N/A |
The number and % of voting rights held | N/A |
The date until which the voting rights will be held | N/A |
11. Additional informationxvi | |
N/A |
Contact name: | Adi Barkan Stern Company Secretary Clal Insurance Enterprises Holdings Ltd |
Contact Telephone: | +972-3-6387634 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.